Anzeige
Mehr »
Login
Sonntag, 05.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
InnoCan Pharma: Multi-Milliarden-Wert in diesem Pennystock?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
18 Leser
Artikel bewerten:
(0)

VIDEO from Medialink and ViaCell: Study Looking to Extend Fertility in Women Begins


NEW YORK, March 22 /PRNewswire/ -- A growing number of women are now having their first babies well into their thirties -- and even in their forties. There are several reasons for waiting to start a family. Women who wait usually have more financial security, more emotional maturity and more time to commit to their marriages and their careers before focusing their energy on children.

(See video from ViaCell at: http://media.medialink.com/WebNR.aspx?story=33180)

Unfortunately, it's a biological reality that the female egg becomes less viable over time -- unlike male sperm. The egg cell is also much harder to freeze because it contains a lot of water that can crystallize during the freezing process.

Now, a company called ViaCell is testing a new technique that is designed to protect the egg during freezing. The multiple site clinical trial is expected to enroll approximately three hundred healthy women, age twenty-one to thirty-five, who are currently seeking fertility treatment to demonstrate births from previously frozen eggs. Currently, there is not an FDA approved product for egg freezing.

The study is expected to be completed in 2009 -- and if the results are positive, it may give women more options when planning their families.

Registered journalists can access video, audio, text, graphics and photos for free and unrestricted use at http://media.medialink.com/.

03NY07-0136
Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2007 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.